Anxiety Reduction Interventions for Stroke Survivors

N/A

Recruiting

Led By Bibi Sangster

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 3

Awards & highlights

No Placebo-Only Group

Summary

This trial studies how reducing anxiety in stroke patients after discharge can improve health outcomes. Patients will receive anxiety reduction interventions and be surveyed at 3 months.

Who is the study for?

This trial is for individuals who have recently had an acute stroke and are stable enough to be discharged home. They must be able to understand and communicate in English, not have cognitive impairments, have internet access including email, and be willing to participate in an anxiety reduction program.

What is being tested?

The study tests the effectiveness of the 'Anxiety Reduction Bundle' on stroke patients after they return home. Participants will use online resources and attend support groups over three months, with their anxiety levels measured before and after using a survey.

What are the potential side effects?

Since this intervention involves non-medical methods like education and support groups for reducing anxiety post-stroke, there may not be direct side effects as seen with medications; however, individual experiences may vary.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in GAD-7 Score from Baseline to Month 3

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients discharged following acute care strokeExperimental Treatment1 Intervention

Participation will last 3 months from enrollment. Demographic data will be retrieved from the electronic health record and the Generalized Anxiety Disorder-7 (GAD-7) Anxiety Questionnaire will be administered at baseline. Participants will repeat the GAD-7 in 3 months and an additional qualitative survey on their experience including an evaluation of the structured anxiety reduction program.

Do I qualify?Apply below to find out